NCT06391814Completed
Donor-Derived EBV-Specific T Cells for Life Threatening EBV-lymphoma (OLIP-EBV-TCL-01-HMR01)
Open-Label Individual Patient Study of Epstein-Barr Virus (EBV) Specific T-Cell Lines for the Treatment of a Lymphoproliferative Disease and Hemophagocytic Syndrome Associated With EBV
Source: ClinicalTrials.gov · Last updated 23 Mar 2026
Brief summary (registry, in English)
Single-patient trial aiming to provide immunological consolidation following allogeneic stem cell transplantation to a young adult patient suffering from a systemic EBV-positive lymphoma of childhood.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 1 (actual)
- First submitted
- 22 Apr 2024
- Start date
- 16 Jan 2024
- Primary completion date
- 5 Apr 2025
- Lead sponsor
- Ciusss de L'Est de l'Île de Montréal
- Diseases
- Childhood cancers
- NCT number
- NCT06391814
What you commit to
- Study type: Interventional
- Participants enrolled: 1
- From 16 Jan 2024 to the primary completion date, 5 Apr 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Administration within less than 28 days of T-cell depleting antibodies (ATG, OKT3, Campath)
Lab values
- Any abnormal condition or laboratory result that is considered by the Principal Investigator capable of altering patient or study outcome.
Other
- Pregnancy
- Active uncontrolled GVHD (acute GVHD grade II-IV or progressive extensive chronic GVHD) at time of enrolment or infusion.
Who the study is looking for
- Capacity to provide informed consent
- Age ≥ 18
- Negative serum pregnancy test and use of effective contraception method.
Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ciusss-Emtl Coordinator of this site? Confirm its status | Montreal | Canada | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.